Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details

EQT, BioNTech investor consider bid for Novartis arm Sandoz -report

Stock Markets Nov 19, 2021 01:11PM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
© Reuters. FILE PHOTO: A general view of the BioNTech building where the production of the coronavirus disease (COVID-19) vaccine has started in Marburg, Germany, November 18, 2021. REUTERS/Fabian Bimmer

By Brenna Hughes Neghaiwi and Ludwig Burger

ZURICH (Reuters) - Investment group EQT (NYSE:EQT) and the Struengmann family, who are investors in BioNTech, are considering a joint offer for Sandoz, the generics arm of Swiss drugmaker Novartis, Handelsblatt reported on Friday.

A potential offer could value Sandoz at more than 20 billion Swiss francs ($21.6 billion), the German daily newspaper reported, citing unnamed sources.

After years of revamping the business, Novartis in October raised the prospect of divesting Sandoz, as price pressures mount in the off-patent drug sector.

It said it had begun a strategic review which would "explore all options, ranging from retaining the business to separation".

The Struengmann family and EQT, who have already made several joint investments, were looking to bring further investors on board in a consortium, Handelsblatt reported.

Several other private equity firms have taken an interest in Sandoz, the newspaper report added.

EQT and Novartis declined to comment. The Struengmann family office could not immediately be reached for comment.

Sandoz would be a return to their roots for biotech investors Thomas and Andreas Struengmann, who sold generic drugs business Hexal to Novartis in 2005. Hexal became part of Sandoz.

The Struengmann twins were early backers of BioNTech when it was founded in 2008 and remain major shareholders in the group that together with Pfizer Inc (NYSE:PFE) has developed one of the leading COVID-19 vaccinations in response to the pandemic.

They have also retained some generic drug activities, such as their ownership of Uruguay-based Mega Pharma SA.

For Novartis, a divestment would further simplify its structure after it spun off the Alcon (NYSE:ALC) eye care business in 2019 and this month agreed to sell a nearly one-third voting stake in Roche back to its cross-town rival.

($1 = 0.9268 Swiss francs)

EQT, BioNTech investor consider bid for Novartis arm Sandoz -report
 

Related Articles

Tesla's Sales of China-made EVs Up 142% in June
Tesla's Sales of China-made EVs Up 142% in June By Investing.com - Jul 06, 2022

By Senad Karaahmetovic Tesla (NASDAQ:TSLA) sold roughly 78,000 China-made cars last month, up 142% from May, according to the preliminary data announced by China Passenger Car...

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email